CD221 or insulin-like growth factor 1 receptor [title] - Search Results

Year	Number of Results
1986	1
1988	1
1989	1
1991	3
1992	4
1993	4
1994	2
1995	5
1996	9
1997	8
1998	7
1999	14
2000	7
2001	10
2002	6
2003	20
2004	22
2005	13
2006	16
2007	25
2008	35
2009	40
2010	51
2011	53
2012	45
2013	72
2014	60
2015	55
2016	54
2017	41
2018	37
2019	33
2020	27
2021	19
2022	25
2023	26
2024	6

1

Fine-Tuning Cardiac Insulin-Like Growth Factor 1 Receptor Signaling to Promote Health and Longevity.

Abdellatif M, Trummer-Herbst V, Heberle AM, Humnig A, Pendl T, Durand S, Cerrato G, Hofer SJ, Islam M, Voglhuber J, Ramos Pittol JM, Kepp O, Hoefler G, Schmidt A, Rainer PP, Scherr D, von Lewinski D, Bisping E, McMullen JR, Diwan A, Eisenberg T, Madeo F, Thedieck K, Kroemer G, Sedej S. Abdellatif M, et al. Circulation. 2022 Jun 21;145(25):1853-1866. doi: 10.1161/CIRCULATIONAHA.122.059863. Epub 2022 May 26. Circulation. 2022. PMID: 35616058 Free PMC article.

2

Insulin-like growth factor-1 receptor controls the function of CNS-resident macrophages and their contribution to neuroinflammation.

Ivan DC, Berve KC, Walthert S, Monaco G, Borst K, Bouillet E, Ferreira F, Lee H, Steudler J, Buch T, Prinz M, Engelhardt B, Locatelli G. Ivan DC, et al. Acta Neuropathol Commun. 2023 Mar 8;11(1):35. doi: 10.1186/s40478-023-01535-8. Acta Neuropathol Commun. 2023. PMID: 36890580 Free PMC article.

3

Insulin-like growth factor 1 receptor mediates photoreceptor neuroprotection.

Rajala A, Teel K, Bhat MA, Batushansky A, Griffin TM, Purcell L, Rajala RVS. Rajala A, et al. Cell Death Dis. 2022 Jul 15;13(7):613. doi: 10.1038/s41419-022-05074-3. Cell Death Dis. 2022. PMID: 35840554 Free PMC article.

4

Blocking insulin-like growth factor 1 receptor signaling pathway inhibits neuromuscular junction regeneration after botulinum toxin-A treatment.

Ishihara H, Otani Y, Tanaka K, Miyajima H, Ngo HX, Fujitani M. Ishihara H, et al. Cell Death Dis. 2023 Sep 16;14(9):609. doi: 10.1038/s41419-023-06128-w. Cell Death Dis. 2023. PMID: 37717026 Free PMC article.

5

Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma.

Akshintala S, Sundby RT, Bernstein D, Glod JW, Kaplan RN, Yohe ME, Gross AM, Derdak J, Lei H, Pan A, Dombi E, Palacio-Yance I, Herrera KR, Miettinen MM, Chen HX, Steinberg SM, Helman LJ, Mascarenhas L, Widemann BC, Navid F, Shern JF, Heske CM. Akshintala S, et al. Clin Cancer Res. 2023 Sep 1;29(17):3329-3339. doi: 10.1158/1078-0432.CCR-23-0709. Clin Cancer Res. 2023. PMID: 37398992 Free PMC article. Clinical Trial.

6

Insulin-like growth factor-1 receptor crosstalk with integrins, cadherins, and the tumor microenvironment: sticking points in understanding IGF1R function in cancer.

Galifi CA, Wood TL. Galifi CA, et al. Endocr Relat Cancer. 2023 Aug 25;30(10):e230031. doi: 10.1530/ERC-23-0031. Print 2023 Oct 1. Endocr Relat Cancer. 2023. PMID: 37490874 Review.

7

Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma.

Eich ML, Tregnago AC, Faraj SF, Palsgrove DN, Fujita K, Bezerra SM, Munari E, Sharma R, Chaux A, Netto GJ. Eich ML, et al. Virchows Arch. 2019 Jan;474(1):21-27. doi: 10.1007/s00428-018-2468-0. Epub 2018 Oct 18. Virchows Arch. 2019. PMID: 30338346 Free PMC article.

8

Targeting insulin-like growth factor-1 receptor (IGF1R) for brain delivery of biologics.

Alata W, Yogi A, Brunette E, Delaney CE, van Faassen H, Hussack G, Iqbal U, Kemmerich K, Haqqani AS, Moreno MJ, Stanimirovic DB. Alata W, et al. FASEB J. 2022 Mar;36(3):e22208. doi: 10.1096/fj.202101644R. FASEB J. 2022. PMID: 35192204

9

Role of Insulin-like Growth Factor 1 Receptor Signaling in Stem Cell Stemness and Therapeutic Efficacy.

Teng CF, Jeng LB, Shyu WC. Teng CF, et al. Cell Transplant. 2018 Sep;27(9):1313-1319. doi: 10.1177/0963689718779777. Epub 2018 Jun 8. Cell Transplant. 2018. PMID: 29882416 Free PMC article. Review.

10

Targeting insulin-like growth factor 1 receptor in sarcomas.

Scotlandi K, Picci P. Scotlandi K, et al. Curr Opin Oncol. 2008 Jul;20(4):419-27. doi: 10.1097/CCO.0b013e328302edab. Curr Opin Oncol. 2008. PMID: 18525338 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

751 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

751 results

Results by year